Cloning And Mutagenesis Market Size Will Reach Over USD 9.29 Billion By 2030, At 18.7% CAGR Growth: Polaris Market Research
[115+ Research Pages] The global cloning and mutagenesis market size and share is estimated to generate revenue of $9.29 billion in 2030 and be valued at $2.00 billion in 2021, according to a report by Polaris Market Research, at a compound annual growth rate (CAGR) of 2022. to 18.7% by 2030. The report profiles key market companies with their sales, revenue and strategies including Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., New England Biolabs, Takara Bio Inc., Merck KGaA, Promega Corporation and others.
New York, New York, January. Jan. 17, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research published a new research report titled , "Clones and Mutagenesis Market Share, Size, Trends, Industry Analysis Report, by Product (Clone Kits, Mutagenesis Kits) "; by technology; For final use; by region; Segment Forecasts, 2022-2030. in its research database.
" The global cloning and mutagenesis market size and share is expected to generate revenue of $9.29 billion by 2030 and reach a value of $2.00 billion by 2021, according to a recent study. Growing at a CAGR (CAGR) of 18.7% from 2022 to 2030."
What is cloning and mutagenesis? What is the expected size and share of the cloning and mutagenesis market?
Cloning is the process of engineering the same organism, tissue, biological material or cell, naturally or artificially. Biotechnology techniques are used to carry out artificial cloning technology. Mutagenesis is the process by which an organism's DNA is continuously altered, resulting in genetic mutations. Mutagenesis is an experimental laboratory procedure in which mutations are made in DNA to create gene mutations.
Cloning and mutagenesis are techniques used to study the structure and function of proteins designed to reveal the effects of mutations both in vitro and in vivo. Increasing adoption of cloning and mutagenesis technologies such as PCR due to growing demand for personalized medicine is expected to drive the growth of the cloning and mutagenesis market. Increasing prevalence of genetic diseases and chronic diseases is expected to drive the market growth.
Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/cloning-and-mutagenesis-market/request-for-sample
(A sample of this report is available upon request. The sample report includes a brief introduction to the research report, table of contents, graphical introduction to regional analysis, key market players with their revenue analysis, and our research methodology.)
Example reports we might include:
Latest Report 2030 Industry Introduction, Overview and Detailed Analysis.
Over 115 pages of research reports (updated research).
Provide supervisor-based guidance upon request.
Updated 2022 regional analysis with graphical representation of dimensions, differences and trends
Includes an updated list of tables and figures.
The updated report covers the key players in the market along with their business strategies, sales volume, and revenue analysis.
Major players in the market:
Agilent Technologies Inc.
Thermal Fisher Scientific Inc.
New England Biolab
Takara Bio Inc.
Mark KDGA
Prague Company
Bio-Rad Laboratories Inc.
Danher
Jena Bioscience GmbH
genetic testing
Transgene Biotech Co. Ltd
For more information on key players, download PDF brochure: https://www.polarismarketresearch.com/industry-analysis/cloning-and-mutagenesis-market/request-for-sample
Cover our free sample report
Report presentation, overview and in-depth analysis of the industry
Data breakdown by region, type, player and application
Competitive landscape and market share of major competitors
Over 110 pages of research reports
Provides management training upon request
It covers market presence in various regions by share, size and trends.
Updated list of tables and figures
This report reviews the key players along with their business strategies.
Factors and Fact Research Methods
growth index
An increasing number of innovations and new product launches in the cloning and mutagenesis market are expected to drive the market growth. The increasing popularity of reproductive cloning is expected to fuel the growth of the cloning and mutagenesis industry during the forecast period. Other factors, such as increased use of personalized medicine and rise in cases of genetic disorders and diseases such as cancer and HIV, may contribute to market expansion. Increasing investment by major manufacturers in research and development in the field of genetic diseases is fueling the market demand.
Additionally, increasing focus on protein engineering for therapeutic development is expanding the market growth potential. Technological developments in the field of cloning services, coupled with the growth of synergistic industrial activities, have increased sales in the cloning and mutagenesis market. Increasing strategic collaboration between public and private organizations is another factor expected to accelerate industry growth in the future.
Buy a copy of the report immediately from TOC @ https://www.polarismarketresearch.com/checkouts/19211
Segment analysis
Application Expansion of Cloning Kits for Market Growth: On the basis of product, the market is segmented into cloning kits and mutagenesis kits. The cloning kits segment will lead the market in 2021 as they are used in industries such as biopharmaceuticals, gene therapy and gene analysis. Thus, the increased use of these kits in the biotechnology industry is expected to drive the growth of the cloning and mutagenesis market segment in the coming years.
Thor-PCR cloning technology offers many advantages driving the growth of the industry: Depending on the technology, the market is segmented into Thor-PCR cloning and site-directed mutagenesis. The TOPO PCR cloning segment accounts for the highest revenue share in the cloning and mutagenesis market in 2021 as it offers several advantages over conventional RT-PCR, such as no ligation and cloning limitations, no post-PCR steps and increased efficiency. .
Increased focus of pharmaceutical companies on drug discovery for market expansion: On the basis of end-use, the market is segmented into biopharmaceutical and pharmaceutical companies as well as CRO and CMOS. Pharmaceutical and biopharmaceutical companies accounted for the largest share of revenue in 2021. This increase can be explained by the increasing prevalence of diseases and the increasing focus of pharmaceutical and biopharmaceutical companies on drug discovery and development.
Inquire more about this report before buying @ https://www.polarismarketresearch.com/industry-analysis/cloning-and-mutagenesis-market/inquire-before-buying
(Ask our sales team to report offers or discounts before purchasing.)
Market overview of cloning and mutagenesis
Report attributes | details |
Estimated income in 2030. | 9.29 billion USD |
Market volume value in 2022. | 2.36 billion US dollars |
Expected growth CAGR | 18.7% from 2022 to 2030 |
primary year | 2022 |
Year of Prophecy | 2022 - 2030 |
The best player in the market | Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., New England Biolabs, Takara Bio Inc., Merck KGaA, Promega Corporation, Bio-Rad Laboratories, Inc., Danaher, Jena Bioscience GmbH, Assay Genie, TransGen Biotech Co., srl |
segment covered | By product, by technology, by end use, by region |
Configuration options | Custom purchase options are available to meet any research need. Explore individual purchase options |
Geographic relief
In terms of geography, the demand for North America cloning and mutagenesis market dominates the market in 2021 owing to the increased demand for biotechnological techniques. Growing adoption of platforms based on genomic and proteomic data, which has led to increased use of cloning and mutagenesis techniques, is driving the growth of the North American market.
Additionally, Asia Pacific is expected to grow at a record rate due to the growing need for new treatments in the region. Other factors supporting the growth of the regional cloning and mutagenesis market include increasing government investment in research and development, rapid economic growth, and accelerated infrastructure development.
View detailed report on Clone and Mutagenesis Market Share, Size, Trends, Industry Analysis Report by Product (Clone Kits, Mutagenesis Kits); by technology; For final use; by region; Segment Forecasts, 2022-2030. With detailed TBS: https://www.polarismarketresearch.com/industry-analysis/cloning-and-mutagenesis-market
For more information or media inquiries, please email: sales@polarismarketresearch.com
Recent improvements
American company Telesis Bio, Inc. announced in May 2021 that its BioXp technology now supports longer fragment cloning. With this effort, researchers can create multidimensional vectors, correct mistakes, and clone arrays into vectors hands-free in a flash.
Frequently Asked Questions
What are the main companies operating in the market?
What are the main rules of the industry affecting the development of the industry?
Which country is the leader in this field?
What types of applications or products will have progressive development opportunities during the forecast period?
What is the expected growth rate of the market during the forecast period?
Polaris Market Research categorizes the Cloning and Mutagenesis market report by product, technology, end user, and region:
By Product Outlook
Clone set
Mutagenesis kit
About Outlook Technology
With the ultimate use of Outlook
by region
North America (USA, Canada)
Europe (France, Germany, Great Britain, Italy, Netherlands, Spain, Russia)
Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
Latin America (Brazil, Mexico, Argentina)
Middle East and Africa (Saudi Arabia, UAE, Israel, South Africa)
See other related reports:
About Polaris Market Research
Polaris Market Research is a global market research and consulting firm. The firm specializes in providing superior market research and in-depth business research services to PMR clients across a range of companies. At Polaris, we are committed to serving PMR's diverse customers spanning the healthcare, technology, semiconductor and chemical industries, as well as many other industries around the world. We strive to provide PMR clients with the latest information on innovative technologies, fast-growing markets, evolving business environments and latest business-oriented applications, thus always helping them make informed decisions and seize new opportunities. With a highly knowledgeable, experienced and highly trained team of SMB representatives, analysts and consultants, we at Polaris are committed to providing value-added business solutions to PMR clients.
Contact:
Leehill G
30 Wall Street
8th Floor,
New York, NY 10005,
United States of America
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Online: https://www.polarismarketresearch.com
Follow us on: Linkedin | Indonesia

Comments
Post a Comment